A study to determine how much margin is to be given around the enlarged pelvic lymph nodes in cervical cancer patients treated with intensity modulated radiation therapy
Not Applicable
- Conditions
- Health Condition 1: null- Cervical cancer
- Registration Number
- CTRI/2016/12/007600
- Lead Sponsor
- PGIMER CHANDIGARH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1.Biopsy proven cancer cervix FIGO stage IB- IIIB
2.Karnofsky Performance Status greater than 70
3.Patient fit for concurrent chemotherapy
4.PET-CT evidence of significant pelvic lymphadenopathy
5.Patientâ??s willingness to give informed consent
Exclusion Criteria
1. post operated cases of cancer cervix
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the expansion margin to be given around the involved pelvic lymph nodes for planning simultaneous integrated boost in patients of cervical cancer undergoing pelvic intensity modulated radiotherapyTimepoint: 6 WEEKS
- Secondary Outcome Measures
Name Time Method ONETimepoint: NONE